Urogen Pharma Stocks Soar 55.93%: New Hires Boost Confidence!

viernes, 6 de junio de 2025, 2:54 pm ET1 min de lectura
URGN--
Urogen Pharma Ltd. rose 55.93% intraday, with the company announcing the grants of inducement restricted stock units ('RSUs') to 27 new employees in connection with their employment with UroGenURGN--. These new team members will support the ongoing commercialization of Jelmyto® (mitomycin) for pyelocalyceal solution, UroGen’s first approved product, and the continued development of the Company’s pipeline.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios